NICE Clears Botox For Chronic Migraine, With Therapy “Stopping Rules”
This article was originally published in The Pink Sheet Daily
Executive Summary
With rules in place about when to stop therapy, the U.K.'s National Institute for Health and Clinical Excellence clears Allergan's botulinum toxin, Botox for use as prophylaxis in patients with chronic migraine and who have tried other therapies.